These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8660053)

  • 1. Thalidomide treatment of mucosal ulcerations in HIV infection.
    Solèr RA; Migliorati C; van Waes H; Nadal D
    Arch Dis Child; 1996 Jan; 74(1):64-5. PubMed ID: 8660053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide for severe aphthous ulceration in patients with human immunodeficiency virus (HIV) infection.
    Oldfield EC
    Am J Gastroenterol; 1994 Dec; 89(12):2276-7. PubMed ID: 7977265
    [No Abstract]   [Full Text] [Related]  

  • 3. Thalidomide treatment of mucosal ulcerations in HIV infection.
    Harry TC
    Arch Dis Child; 1996 Jul; 75(1):90. PubMed ID: 8813889
    [No Abstract]   [Full Text] [Related]  

  • 4. Thalidomide for aphthous ulcers in patients infected with the human immunodeficiency virus.
    Weidle PJ
    Am J Health Syst Pharm; 1996 Feb; 53(4):368, 371-2, 378. PubMed ID: 8673657
    [No Abstract]   [Full Text] [Related]  

  • 5. Thalidomide pros and cons.
    Am J Nurs; 1998 Apr; 98(4):63. PubMed ID: 9556688
    [No Abstract]   [Full Text] [Related]  

  • 6. Thalidomide in oral aphthous ulceration in patients with HIV infection.
    Henriquet F; Roy MT; Repetto T; Fusco F
    Palliat Med; 1994; 8(3):255-6. PubMed ID: 7952375
    [No Abstract]   [Full Text] [Related]  

  • 7. Thalidomide use is associated with weight gain in HIV-1-positive clients.
    Sharp M; Getty J; Klausner JD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Aug; 15(5):392. PubMed ID: 9342262
    [No Abstract]   [Full Text] [Related]  

  • 8. Refractory aphthous ulceration treated with thalidomide: a report of 10 years' clinical experience.
    Cheng S; Murphy R
    Clin Exp Dermatol; 2012 Mar; 37(2):132-5. PubMed ID: 22007681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current role of thalidomide in HIV-positive patients with recurrent aphthous ulcerations.
    Shetty K
    Gen Dent; 2007; 55(6):537-42. PubMed ID: 18050580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide-resistant HIV-associated aphthae successfully treated with granulocyte colony-stimulating factor.
    Manders SM; Kostman JR; Mendez L; Russin VL
    J Am Acad Dermatol; 1995 Aug; 33(2 Pt 2):380-2. PubMed ID: 7542291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of thalidomide against esophageal ulceration in HIV infection].
    Bodokh I; Lacour JP; Rainero C; Castanet J; Michiels JF; Ortonne JP
    Presse Med; 1993 Sep; 22(26):1233. PubMed ID: 8248047
    [No Abstract]   [Full Text] [Related]  

  • 12. Thalidomide in the management of recurrent aphthous ulcerations in patients who are HIV-positive: a review and case reports.
    Shetty K
    Spec Care Dentist; 2005; 25(5):236-41. PubMed ID: 16454100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide for aphthous ulcers in HIV infection.
    Birnkrant D
    N Engl J Med; 1997 Oct; 337(15):1086-7. PubMed ID: 9324641
    [No Abstract]   [Full Text] [Related]  

  • 14. Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers.
    Jacobson JM; Greenspan JS; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Pulvirenti JJ; Hooton TM; Shikuma C
    J Infect Dis; 2001 Jan; 183(2):343-346. PubMed ID: 11120935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thalidomide, the treatment of choice in aphthae in HIV infection].
    Samson J; Kuffer R; Radeff B
    Presse Med; 1990 Apr; 19(15):722. PubMed ID: 2139969
    [No Abstract]   [Full Text] [Related]  

  • 16. Aphthous ulcers in HIV-infected patients: treatment with thalidomide.
    Strazzi S; Lebbe C; Geoffray C; Ablon G; Morel P; Verola O; Molina JM
    Genitourin Med; 1992 Dec; 68(6):424-5. PubMed ID: 1487271
    [No Abstract]   [Full Text] [Related]  

  • 17. Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection.
    Paterson DL; Georghiou PR; Allworth AM; Kemp RJ
    Clin Infect Dis; 1995 Feb; 20(2):250-4. PubMed ID: 7742424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide-associated thrombosis in the treatment of HIV-associated severe aphthous disease: a case report and review of the literature.
    Hodowanec AC; Han A; Barker DE; Rubinstein PG; Max B
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(6):345-7. PubMed ID: 22930795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aphthosis major treated with thalidomide in a patient with AIDS].
    Allegue F; Sarriá Cepeda C; García Rodríguez M
    Enferm Infecc Microbiol Clin; 1991 Feb; 9(2):133-4. PubMed ID: 1854850
    [No Abstract]   [Full Text] [Related]  

  • 20. Aphtha Major Perianalis.
    Guimarães ALM; Lourenço SV; Nico MMS
    J Cutan Med Surg; 2019; 23(1):105-107. PubMed ID: 30192651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.